At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Mometasone Furoate Aqueous Nasal Spray vs Placebo and Flonase® (Fluticasone Propionate) in Seasonal Allergic Rhinitis Patients (I94-001)
In Brief
A Phase 3 clinical trial evaluating Mometasone furoate, Fluticasone propionate, and 2 other interventions for Rhinitis, Allergic, Seasonal. Completed, enrolled 313 participants.
Detailed Summary
The purpose of this study is to evaluate the efficacy and safety of mometasone furoate (SCH 32088) aqueous nasal spray 200 mcg once daily compared to placebo once daily in the treatment of participants with seasonal allergic rhinitis. Flonase (fluticasone propionate) nasal spray 200 mcg once daily has been chosen as the active control for this study.
Study Details
Timeline
Interventions
Mometasone furoate nasal spray, 200 mg once daily
Fluticasone propionate nasal spray, 200 mg once daily
Mometasone furoate placebo matching nasal spray, once daily
Fluticasone propionate placebo matching nasal spray, once daily